本文章的引用
本文章的通讯作者
本文章的研究领域
本文章的类型
本文章的开放获取政策
本文章的Google引用次数
本文章的点击和下载次数
- 本文章浏览次数 (4742)
All Articles published online
|
Publishing Process of This Article
|
2021-02-28 (publication date) through 2024-08-25
本文章的被引频次
本文章的期刊信息
出版物名称
世界华人消化杂志
ISSN
1009-3079
本文章的出版商
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | 黄健翔, 骆旭航, 龚安安. 卡瑞利珠单抗配合TACE对伴微血管侵犯肝细胞癌患者根治术后血清Egfl7、VEGF、OPN水平及复发率影响的前瞻性研究. 世界华人消化杂志 2021; 29(4): 182-189 [DOI: 10.11569/wcjd.v29.i4.182] |
|---|---|
| URL: | https://www.wjgnet.com/1009-3079/full/v29/i4/182.htm |
| 编号 | Citing Articles |
| 1 |
Qing Yang, Gengyu Li, Xiaoqiu Wu, Haiying Lin, Wanrui Wu, Xiangpang Xie, Yu Zhu, Wei Cai, Changsheng Shi, Shengye Zhuo. RETRACTED: A novel therapeutic strategy of combined camrelizumab and apatinib for the treatment of advanced hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1136366
|
| 2 |
Sujing Zhang, Yingchun Zhao, Li He, Changwen Bo, Yonghui An, Na Li, Wenhua Ma, Ying Guo, Yan Guo, Changwang Zhang. Effect of camrelizumab plus transarterial chemoembolization on massive hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2022; 46(4): 101851 doi: 10.1016/j.clinre.2021.101851
|